HIV replicates rapidly and copies itself imprecisely, producing enormous numbers of slightly different variants every day. If a drug is present at a level high enough to pressure the virus but too low to stop it replicating, the variants that happen to tolerate that drug have an advantage and come to dominate. That is the entire mechanism of resistance, and it explains why the pattern of taking medication matters as much as whether you take it.
Why is erratic dosing worse than a clean break?
Because it creates exactly the conditions resistance needs. Full adherence keeps drug levels high enough to prevent replication altogether, so there is nothing to select from. Complete absence removes the pressure, so no variant has an advantage. The dangerous zone is in between: doses missed frequently enough that levels fall below the threshold while the drug is still present. This is why clinics ask about patterns rather than totals, and why stopping treatment should be planned rather than drifted into.
Which regimens are most vulnerable?
Older drug classes had a low barrier to resistance, where a single mutation could confer it. Modern integrase inhibitors such as dolutegravir and bictegravir have a high barrier, requiring several mutations to accumulate before resistance emerges, which is why they tolerate imperfect adherence far better. This is a genuine improvement rather than marketing, though it is not a licence to take treatment casually.
Can you be infected with resistant virus?
Yes. Transmitted resistance occurs when someone acquires a strain that is already resistant to particular drugs. This is why a resistance test is done at diagnosis before treatment starts, so the initial regimen is chosen around what will actually work. Rates of transmitted resistance to first-line drugs in the UK remain low but are monitored.
How is resistance detected?
A genotype test sequences the virus and identifies mutations associated with resistance to specific drugs. It requires a viral load above a certain level to work, which means it cannot be done while you are undetectable. That is one reason a sustained rise in viral load prompts prompt investigation rather than waiting: testing while the level is measurable gives the information needed to choose the next regimen.
What happens if resistance is found?
The regimen is changed to drugs the virus remains susceptible to. There are many options across several classes, and most people who develop resistance to one combination achieve suppression again on another. Options narrow with each episode, which is the argument for identifying and addressing problems early rather than continuing on a failing regimen.
What causes viral rebound apart from resistance?
Adherence is the most common explanation by a wide margin. Absorption problems come next: antacids and supplements containing calcium, magnesium, iron or zinc bind integrase inhibitors in the gut and can reduce levels substantially if taken together. Interactions with other prescribed or recreational drugs, vomiting, and occasionally a supply gap all contribute. Clinics work through these before concluding that the virus has changed.
What should you do?
Take the tablets consistently, separate them from antacids and mineral supplements by several hours, order repeats before you run out, and tell the clinic honestly if adherence has slipped rather than presenting a tidier version. A frank account leads to a regimen that fits your life. An inaccurate one leads to unnecessary changes and lost options.
Does resistance ever go away?
Resistant variants can become undetectable in the blood after a drug is stopped, but the virus keeps an archived record in its reservoir, and the resistant strain reappears if that drug is used again. This is why resistance history is permanent and why clinics keep a record of every genotype result. A drug that failed you five years ago remains off the list.
How worried should you be?
Less than the topic suggests. With current first-line regimens, resistance in someone taking treatment reasonably consistently is uncommon, and most people never encounter it. It matters as a reason to take the tablets properly and to raise adherence problems early, rather than as a likely outcome.
What if you are already resistant to several drugs?
Newer agents with novel mechanisms have expanded the options considerably for people with extensive resistance, including long-acting treatments given every six months. This is specialist territory, and referral to a service with particular expertise is reasonable to ask for.